3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Cardiotoxicity
4
Prostatic Neoplasms
3
Lung Neoplasms
3
Hematologic Neoplasms
3
Heart Failure
3
Small Cell Lung Carcinoma
2
Multiple Myeloma
2
Leukemia
2
Carcinoma in Situ
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Ventricular Dysfunction, Left
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Peritoneal Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Nose Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Interventions
Aspirin
4
Blood Pressure
3
Vitamin E
2
Vitamin D
2
Nutrition Assessment
2
Metformin
2
Geritol
2
Diet, Mediterranean
2
Cholecalciferol
2
phosphoribosylformylglycinamidine synthetase
1
glycidol
1
ficlatuzumab
1
beta Carotene
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Vascular Stiffness
1
Tumor Necrosis Factor Inhibitors
1
Therapeutics
1
Sugars
1
Spironolactone
1
Resistance Training
1
Raloxifene Hydrochloride
1
Pulse Wave Analysis
1
Progestins
1
Physical Conditioning, Human
1
Omeprazole
1
Noninvasive Prenatal Testing
1
Naproxen
1
Methods
1
Lysine Acetyltransferase 5
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cardiovascular Diseases
×
Electrocardiography
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled